Top news of the week: 25.02.2020.
Biotechnology, Pharmacology, Oncology, Rare disease, Middle East, Biology
Startups
Former Amgen EVP R&D Sean Harper & ex Amgen SVP & ex Kleiner Perkins partner Beth Seidenberg discuss their LA-based VC fund w/ @amirahalidrus. Sean said he was spending $4B/yr in prev job, now investing $15-$20M 2start a biotech https://t.co/VE07h8fBcy 1/3
Open'Closer to the science': Why Amgen vets Harper and Seidenberg set up their own VC shop
After 17 years at Amgen, head of R&D Sean Harper was ready to get closer to the science. He reunited with his former colleague from Merck and Amgen, Beth Seidenberg, in Los Angeles and set ...
Crossover round, check. New team of biopharma execs, check. Now, Imara wants an IPO https://t.co/fi7qE2KiES https://t.co/lH6m6hKm9x
OpenCrossover round, check. New team of biopharma execs, check. Now, Imara wants an IPO
Imara is looking to cap a good 2019 with an initial public offering in 2020. The rare disease biotech wants $86 million on the Nasdaq.
RT @adamfeuerstein: In a cramped Kendall Square, biotech startups sublet desks and squeeze into shared labs https://t.co/63Kb3I6OmC via @sheridan_kate
OpenIn a cramped Kendall Square, biotech startups sublet desks and squeeze into shared labs
As the vacancy rate for commercial lab spaces plummets, biotech companies are squeezing into any space they can find â like other companies' labs.
Artificial Intelligence Model Identifies âAmazingâ Antibiotic Candidate https://t.co/WIQet3C1S0 #AMR https://t.co/B5JZadBeEH
OpenArtificial Intelligence Model Identifies âAmazingâ Antibiotic Candidate
MIT researcher claims newly discovered antibacterial compound could be "arguably one of the more powerful antibiotics that has been discovered."
Well there you go. Emergency over. $INO developed a new coronavirus vaccine in 3 hours and is confident after having done this several times already. Of course....And people believe it
https://t.co/vsAIK29Asn
OpenAmerican biotech company claims it developed a vaccine for COVID-19 in just 3 hours
Inovio Pharmaceuticals, claims that it had developed a vaccine within three hours after the genetic sequence was made available
In raw numbers, 2019 saw fewer IPOs in healthcare than 2018 did. Despite that decline, the sector outraised itself, banking more in total proceeds than the year before. https://t.co/g93tqf9DOY
OpenTop 10 biotech IPOs in 2019
The big question at the start of 2019 was whether the IPO window would stay open for biotech companies, particularly those seeking to pull off ever-larger IPOs at increasingly earlier ...
Israeli biotech NeoTX lands $45M series C for combo I-O cancer trials https://t.co/KKu231oD7X https://t.co/nj3kBobPed
OpenIsraeli biotech NeoTX lands $45M series C for combo I-O cancer trials
NeoTX Therapeutics has nabbed a healthy $45 million third funding round as it looks to continue work on its early-stage cancer combo test and in-license new tech.
The Massachusetts Next Generation Initiative identifies promising women-led life sciences companies and provides critical funding and access to a robust panel of executive coaches to ensure that they have important resources to succeed.
đ https://t.co/YgHshxbtdr https://t.co/Sr8QaadXCE
OpenMassachusetts Next Generation Initiative
Program Overview The Massachusetts Next Generation Initiative (MassNextGen) is a five year, over $2 million commitment to ensure greater gender parity in the next generation of âŚ